Trial reportPain research & management2026
Comparative Analgesic Efficacy of Diclofenac and Ketoprofen Transdermal Patches Versus Ibuprofen Tablets for Pain Control After Initial Archwire Placement in Orthodontic Patients: A Randomized Clinical Trial.
Trial report in Pain research & management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesThis study compared the analgesic efficacy of diclofenac and ketoprofen transdermal patches versus ibuprofen tablets for pain control following initial archwire placement in orthodontic patients. MATERIALS AND
methodsIn this randomized clinical trial, 60 patients (aged 15-30 years) undergoing fixed orthodontic treatment (0.022-inch MBT brackets and 0.014-inch nickel-titanium archwires on both arches) were assigned via stratified permuted block randomization (1:1:1 ratio) to three groups (n = 20 each): 30-mg ketoprofen transdermal patches every 12 h, 15-mg diclofenac transdermal patches every 12 h, or 400-mg ibuprofen tablets every 8 h for 1 day. Pain severity was assessed using the numeric rating scale (NRS; 0-10) at baseline (immediately postplacement), 2 and 6 h, bedtime, 24 and 48 h, and 3 and 7 days. Data were analyzed by the generalized estimating equation (GEE) and the Kruskal-Wallis, Bonferroni, chi-square, and Fisher's exact tests (α = 0.05).
resultsThe pain score was the lowest in the ketoprofen group, followed by the ibuprofen group, and then the diclofenac group, but the difference was not significant (p > 0.05). The pain score initially increased after archwire placement to 6 h (from 0 pain in all groups to 2.50 ± 1.64, 3.90 ± 1.25, and 3.45 ± 1.82, respectively, in ketoprofen, diclofenac, and ibuprofen groups). It subsequently decreased until bedtime, increased again at 24 h, and then followed a descending trend from 48 h to 7 days. The trend of change in the pain score over time was not significantly different among the three groups (p = 0.657). Age (p = 0.757) and gender (p = 0.153) of patients did not affect their perceived pain.
conclusionConsidering the comparable analgesic efficacy of ibuprofen and the tested transdermal patches, diclofenac and ketoprofen patches may be used as an alternative to ibuprofen tablets for efficient pain control after initial archwire placement.
trial registrationIranian Registry of Clinical Trials: IRCT20190915044771N2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.